The Generic Drugs Market: 2015 – 2030 - Opportunities, Challenges, Strategies & Forecasts
Published: Feb 2015 Single User PDF: US$ 2500 Corporate User PDF: US$ 3500
Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any.
Š ReportsnReports.com / Contact
The Generic Drugs Market: 2015 – 2030 Opportunities, Challenges, Strategies & Forecasts A generic drug is a pharmaceutical product, usually intended to be interchangeable with an innovator product that is manufactured without a license from the innovator company and marketed after the expiry date of the patent or other exclusive rights. Already prevalent in the U.S., Europe and much of the developing world, generic drugs market is now finding their way into previously untapped markets such as Japan, largely driven by regulatory efforts to reduce healthcare costs. The report estimates that the market for generic drugs will account for nearly $350 Billion in revenue by the end of 2015. Despite challenges relating to quality control and legal concerns, the market is poised for significant growth in the coming years. The market is expected to grow at a CAGR of 12% between 2015 and 2020, driven by growth in both established and developing markets.
Complete Report is Available @ http://www.reportsnreports.com/reports/344436-the-generic-drugs-market-2015-2030-opportunities-challenges-strategies-forecasts.html .
Š ReportsnReports.com / Contact
The Generic Drugs Market: 2015 – 2030 Opportunities, Challenges, Strategies & Forecasts The “Generic Drugs Market: 2015 – 2030 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of the generic drugs ecosystem including technology, economics, key trends, market drivers, challenges, investment potential, regulatory landscape, leading therapies, opportunities, future road map, value chain, ecosystem player profiles and strategies. The report also presents market size forecasts for generic drugs from 2015 through to 2030. The forecasts are segmented for over 10 therapeutic areas, 3 brand classifications, 5 regions and 25 leading countries. The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.
Single User License of the Report is Available at USD 2500, Buy the Report @ http://www.reportsnreports.com/Purchase.aspx?name=344436 .
© ReportsnReports.com / Contact
The Generic Drugs Market: 2015 – 2030 Opportunities, Challenges, Strategies & Forecasts Key Findings: Generic drugs will account for nearly $350 Billion in revenue by the end of 2015. The market is further expected to grow at a CAGR of 12% over the next five years. As the market consolidates, larger players continue to grow their market share on the heels of acquisitions and mergers. Well established players are particularly keen to capitalize on joint ventures in untapped markets such as Japan. In order to overcome low margins, some generic drug manufacturers are venturing into the super generics opportunity. Sold for a significantly higher price than their pure generic counterparts, super generics account for 18% of all spending on generic drugs. In a bid to control costs and expand their global reach, generic drug manufacturers are complementing their existing manufacturing and R&D locations with sites in low cost countries such as India, China and Russia. Driven by the cost saving potential of biosimilar drugs, a number of countries have established regulatory pathways for their approval. We estimate that approved biosimilar drugs will account for more than $20 Billion in revenue by the end of 2020. Complete Report is Available @ http://www.reportsnreports.com/reports/344436-the-generic-drugs-market-2015-2030-opportunities-challenges-strategies-forecasts.html .
Š ReportsnReports.com / Contact
The Generic Drugs Market: 2015 – 2030 Opportunities, Challenges, Strategies & Forecasts Topics Covered: Generic drugs ecosystem Market drivers and barriers Technology, economics and key trends Pure, branded and super generics Analysis of key therapeutic areas and leading generic drugs Regulatory landscape of generic drugs throughout the globe Industry road map and value chain Profiles and strategies of over 130 leading ecosystem players, including generic and innovator drug manufacturers Strategic recommendations for ecosystem players Market analysis and forecasts from 2015 till 2030
Get discount on the Report @ http://www.reportsnreports.com/contacts/Discount.aspx?name=344436 .
Š ReportsnReports.com / Contact
The Generic Drugs Market: 2015 – 2030 Opportunities, Challenges, Strategies & Forecasts Historical Revenue & Forecast Segmentation: Market forecasts are provided for each of the following sub markets and their subcategories: Brand Classification Pure (Non-branded) Generics Branded Generics Super Generics
Inquire Before buying the Report @ http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=344436 .
Š ReportsnReports.com / Contact
The Generic Drugs Market: 2015 – 2030 Opportunities, Challenges, Strategies & Forecasts Therapeutic Area Antibiotics Cardiovascular & Hypertension CNS (Central Nervous System) Dermatology Diabetes Gastrointestinal Hormonal Drugs Oncology Pain Relief Respiratory Rheumatology Others Inquire Before buying the Report @ http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=344436 .
Š ReportsnReports.com / Contact
The Generic Drugs Market: 2015 – 2030 Opportunities, Challenges, Strategies & Forecasts Regional Markets Asia Pacific Europe Middle East & Africa North America Latin & Central America
Get discount on the Report @ http://www.reportsnreports.com/contacts/Discount.aspx?name=344436 .
Š ReportsnReports.com / Contact
The Generic Drugs Market: 2015 – 2030 Opportunities, Challenges, Strategies & Forecasts Key Questions Answered: How big is the generic drugs opportunity? What trends, challenges and barriers are influencing its growth? How is the ecosystem evolving by segment and region? What will the market size be in 2020 and at what rate will it grow? Which countries and sub markets will see the highest percentage of growth? How big is the market for generic cancer drugs? How does regulation impact the adoption of generic drugs? How will branded and super generics impact revenue prospects? Who are the key market players and what are their strategies? How will patent expirations of biologics impact the market? What are the future prospects of approved and non-approved biosimilar drugs? What strategies should generic and innovator drug manufacturers adopt to remain competitive? Reach us at + 1 888 391 5441 | sales@reportsandreports.com
Š ReportsnReports.com / Contact
The Generic Drugs Market: 2015 – 2030 Opportunities, Challenges, Strategies & Forecasts List of Companies Mentioned Abbott Laboratories AbbVie ACETO Corporation Acino Holding Actavis Actelion Adcock Ingram Aesica Pharmaceuticals Ajinomoto Akron Alexion Pharmaceuticals View all vendors Reach us at + 1 888 391 5441 | sales@reportsandreports.com
Š ReportsnReports.com / Contact